CYP2D6 genotype and adverse drug reaction in the ICU

被引：0
|
作者：
Stamer, UM [1 ]
Bayerer, B [1 ]
Hoeft, A [1 ]
Stüber, F [1 ]
机构：
[1] Univ Bonn, Dept Anaesthesiol & Intens Care Med, Bonn, Germany
来源：
INTENSIVE CARE MEDICINE | 2003年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
34
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [21] An overview on the allelic variant of CYP2D6 genotype
    Mathew, Shiju
    AFRICAN JOURNAL OF BIOTECHNOLOGY, 2010, 9 (54): : 9096 - 9102
  • [22] CYP2D6 genotype and treatment with tricyclic antidepressants
    Tandon, K
    Schalkwyk, L
    Checkley, S
    Patel, M
    Kinirons, M
    Kerwin, RW
    McGuffin, P
    Aitchison, KJ
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 114 (07): : 775 - 775
  • [23] CYP2D6 GENOTYPE DETERMINATION IN THE DANISH POPULATION
    BROSEN, K
    NIELSEN, PN
    BRUSGAARD, K
    GRAM, LF
    SKJODT, K
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 47 (03) : 221 - 225
  • [24] CYP2D6 Reduced Function Variants and Genotype/Phenotype Translations of CYP2D6 Intermediate Metabolizers: Implications for Personalized Drug Dosing in Psychiatry
    Molden, Espen
    Jukic, Marin M.
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [25] Quantitative assessment of the effect of CYP2D6 genotype on tamoxifen metabolism: A model for CYP2D6 genotype-phenotype studies.
    Borges, S
    Desta, Z
    Jin, Y
    Li, L
    Skaar, TC
    Flockhart, DA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P34 - P34
  • [26] Serum flecainide S/R ratio reflects the CYP2D6 genotype and changes in CYP2D6 activity
    Doki, Kosuke
    Sekiguchi, Yukio
    Kuga, Keisuke
    Aonuma, Kazutaka
    Homma, Masato
    DRUG METABOLISM AND PHARMACOKINETICS, 2015, 30 (04) : 257 - 262
  • [27] Curbing Adverse Effects of CYP2D6 Substrates
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (05) : 933 - 933
  • [28] CYP2D6 Genotyping and Inhibition as Predictors of Adverse Drug Reactions in Depressive Disorders
    Holck, Amanda
    Asp, Marie
    Green, Henrik
    Westrin, Asa
    Reis, Margareta
    JOURNAL OF CLINICAL PSYCHIATRY, 2024, 85 (01)
  • [29] IN VITRO COMPARATIVE INHIBITORY PROFILES OF SEVERAL CYP2D6 INHIBITORS AND METABOLIC CAPABILITIES OF CYP2D6*1, CYP2D6*2, CYP2D6*10, AND CYP2D6*17 ON TRAMADOL METABOLISM
    Nahid, N.
    Kanumuri, S.
    Sharma, A.
    Wang, D.
    Johnson, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S74 - S75
  • [30] Interrogation of CYP2D6 Structural Variant Alleles Improves the Correlation Between CYP2D6 Genotype and CYP2D6-Mediated Metabolic Activity
    Dalton, Rachel
    Lee, Seung-been
    Claw, Katrina G.
    Prasad, Bhagwat
    Phillips, Brian R.
    Shen, Danny D.
    Wong, Lai Hong
    Fade, Mitch
    McDonald, Matthew G.
    Dunham, Maitreya J.
    Fowler, Douglas M.
    Rettie, Allan E.
    Schuetz, Erin
    Thornton, Timothy A.
    Nickerson, Deborah A.
    Gaedigk, Andrea
    Thummel, Kenneth E.
    Woodahl, Erica L.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (01): : 147 - 156
12345